Inato

Headquartered in France, Inato is a technology platform company connecting clinical research trials with physicians. The company primarily supports stakeholders through its Inato Marketplace, which connects research sponsors, clinical research sites, and consulting physicians. In terms of business model, the company charges research sponsors for the use of its platform, while offering it free of charge for physicians and clinical research sites that want to sign up.

The platform allows research sponsors to screen from a pool of research sites to identify the sites that best meet the objectives of the research team through the use of structured applications and the alignment of incentives with the clinical trial’s objectives. In addition to more effective site identification, the platform also helps reduce the time taken to sign up and the costs incurred by providing end-to-end support to research sponsors.

Key customers and partnerships

As of June 2024, 3,000+ trial sites were on the company’s platform, which also operated across 70+ countries. Its customer base as of the same date included companies such as Sanofi.

Funding and financials

In March 2023, Inato raised USD 20 million in Series A2 funding, led by Cathay Innovation. The proceeds were to be used for product innovation and refining its data model for better community site and sponsor trial matching, along with global expansion and talent acquisition.